Essential Revision Notes for MRCP Third Edition - PasTest
Essential Revision Notes for MRCP Third Edition - PasTest
Essential Revision Notes for MRCP Third Edition - PasTest
- No tags were found...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Cardiologyor alter the rhythm:• Surprisingly, rhythm control does not reduce therisk of stroke (indeed paroxysmal AF carries thesame stroke risk as chronic AF) and there<strong>for</strong>edoes not affect the indications <strong>for</strong>anticoagulation• Cardioversions, multiple drugs and ablations areall used to alter rhythm• In asymptomatic individuals rate control isrecommendedAssociations with atrial ¢brillation• Ischaemic heart disease• Pericarditis• Mitral valve disease• Pulmonary embolus• Hypertension• Atrial myxomas• Thyroid disease• LVH• Acute alcohol excess/chronic alcoholiccardiomyopathy• ASD• Post-coronary artery bypass graft (CABG)• Caffeine excess• Dilated left atrium (.4.5 cm)• Pneumonia• WPW syndrome• Bronchial malignancy• Risk factors <strong>for</strong> stroke with non-valvular AF• Previous history of cerebrovascularaccident or transient ischaemic attack(risk 322.5)• Diabetes (31.7)• Hypertension (31.6)• Heart failure• Risk factors <strong>for</strong> recurrence of AF aftercardioversion• Long duration (.1–3 years)• Rheumatic mitral valve disease• Left atrium size .5.5 cm• Older age (.75 years)• Left ventricular impairmentThe CHADS 2 score can be used <strong>for</strong> stratifyingthromboembolic risk in AF:• 1 point is awarded <strong>for</strong> each of: congestiveheart failure, hypertension, age over 75,diabetes• 2 points are awarded <strong>for</strong> systemic emboli• A score of 3 indicates a high risk ofthrombus <strong>for</strong>mation and is a strongindication <strong>for</strong> anticoagulation• Scores of 1 and 2 are intermediate values(anticoagulation is given at the discretion ofthe physician)• The score has the virtue of simplicity but isquite conservative, probablyunderestimating the risk associated withprior stroke/transient ischaemic attackThe overall risk of systemic emboli is 5%–7%annually (higher with rheumatic valve disease); thisfalls to 1.6% with anticoagulation. Transoesophagealechocardiography (TOE) may exclude atrialappendage thrombus but cannot predict thedevelopment of a thrombus in the early stages postcardioversion;anticoagulation is there<strong>for</strong>e alwaysrecommended post-cardioversion.1.5.4 Ventricular arrhythmias andchannelopathiesVentricular tachycardia (monomorphic)Ventricular tachycardia (VT) has a poor prognosiswhen left ventricular function is impaired. After theexclusion of reversible causes such patients may27